Natus Medical upgraded at Raymond James

theflyonthewall.com

As previously reported, Raymond James upgraded Natus Medial to Outperform from Market Perform. The firm upgraded shares citing the recent pullback and significant margin expansion opportunities. Price target is $15.

Rates

View Comments (0)